This opportunity is no longer accepting applications.
grant NOT-DA-24-004
Notice of Special Interest (NOSI) Targeting Epigenetic Regulators for Treating Addiction and Substance Use Disorders
This grant opportunity invites researchers to conduct basic preclinical studies on enzymes and pathways involved in epigenetic changes caused by addictive drugs. The research aims to develop new drugs, methods, and treatments for substance use disorders and addiction.
The goal of this announcement is to encourage basic preclinical research aimed at identifying and targeting specific enzymes and pathways that play a key role in epigenetic changes induced by addictive drugs with the goal of developing pharmacological tools, methods, and therapeutic intervention…
Funding Source
Agency: National Institutes of Health
Sub-agency: National Institute on Drug Abuse
Dates
Opportunity Released: November 3, 2022
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers